243 related articles for article (PubMed ID: 34278602)
1. Osteal macrophages support osteoclast-mediated resorption and contribute to bone pathology in a postmenopausal osteoporosis mouse model.
Batoon L; Millard SM; Raggatt LJ; Wu AC; Kaur S; Sun LWH; Williams K; Sandrock C; Ng PY; Irvine KM; Bartnikowski M; Glatt V; Pavlos NJ; Pettit AR
J Bone Miner Res; 2021 Nov; 36(11):2214-2228. PubMed ID: 34278602
[TBL] [Abstract][Full Text] [Related]
2. CD169
Batoon L; Millard SM; Wullschleger ME; Preda C; Wu AC; Kaur S; Tseng HW; Hume DA; Levesque JP; Raggatt LJ; Pettit AR
Biomaterials; 2019 Mar; 196():51-66. PubMed ID: 29107337
[TBL] [Abstract][Full Text] [Related]
3. Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis.
Liu Z; Liang W; Kang D; Chen Q; Ouyang Z; Yan H; Huang B; Jin D; Chen Y; Li Q
Clin Interv Aging; 2020; 15():1201-1212. PubMed ID: 32764906
[TBL] [Abstract][Full Text] [Related]
4. Effects of JSOG-6 on protection against bone loss in ovariectomized mice through regulation of osteoblast differentiation and osteoclast formation.
Chung HJ; Cho L; Shin JS; Lee J; Ha IH; Park HJ; Lee SK
BMC Complement Altern Med; 2014 Jun; 14():184. PubMed ID: 24903150
[TBL] [Abstract][Full Text] [Related]
5. AS-605240 Blunts Osteoporosis by Inhibition of Bone Resorption.
Sun J; Cai G; Shen J; Cheng P; Zhang J; Jiang D; Xu X; Lu F; Chen L; Chen H
Drug Des Devel Ther; 2023; 17():1275-1288. PubMed ID: 37138583
[TBL] [Abstract][Full Text] [Related]
6. Anti-c-fms Antibody Prevents Osteoclast Formation and Bone Resorption in Co-Culture of Osteoblasts and Osteoclast Precursors In Vitro and in Ovariectomized Mice.
Nara Y; Kitaura H; Ogawa S; Shen WR; Qi J; Ohori F; Noguchi T; Marahleh A; Pramusita A; Kinjo R; Mizoguchi I
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32854340
[TBL] [Abstract][Full Text] [Related]
7. Extract of Magnoliae Flos inhibits ovariectomy-induced osteoporosis by blocking osteoclastogenesis and reducing osteoclast-mediated bone resorption.
Jun AY; Kim HJ; Park KK; Son KH; Lee DH; Woo MH; Kim YS; Lee SK; Chung WY
Fitoterapia; 2012 Dec; 83(8):1523-31. PubMed ID: 22981503
[TBL] [Abstract][Full Text] [Related]
8. Critical role of beta3 integrin in experimental postmenopausal osteoporosis.
Zhao H; Kitaura H; Sands MS; Ross FP; Teitelbaum SL; Novack DV
J Bone Miner Res; 2005 Dec; 20(12):2116-23. PubMed ID: 16294265
[TBL] [Abstract][Full Text] [Related]
9. Strain-dependent variations in the response of cancellous bone to ovariectomy in mice.
Iwaniec UT; Yuan D; Power RA; Wronski TJ
J Bone Miner Res; 2006 Jul; 21(7):1068-74. PubMed ID: 16813527
[TBL] [Abstract][Full Text] [Related]
10. Osteal tissue macrophages are intercalated throughout human and mouse bone lining tissues and regulate osteoblast function in vitro and in vivo.
Chang MK; Raggatt LJ; Alexander KA; Kuliwaba JS; Fazzalari NL; Schroder K; Maylin ER; Ripoll VM; Hume DA; Pettit AR
J Immunol; 2008 Jul; 181(2):1232-44. PubMed ID: 18606677
[TBL] [Abstract][Full Text] [Related]
11. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.
Kim TH; Jung JW; Ha BG; Hong JM; Park EK; Kim HJ; Kim SY
J Nutr Biochem; 2011 Jan; 22(1):8-15. PubMed ID: 20233653
[TBL] [Abstract][Full Text] [Related]
12. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
13. Anti-Osteoporotic Effects of
Lim HJ; Park EJ; Won YS; Bak SG; Cheong SH; Lee SW; Lee S; Lee SJ; Rho MC
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833909
[TBL] [Abstract][Full Text] [Related]
14.
Han SY; Kim JH; Jo EH; Kim YK
Molecules; 2021 Mar; 26(7):. PubMed ID: 33810474
[TBL] [Abstract][Full Text] [Related]
15. A novel anti-osteoporotic agent that protects against postmenopausal bone loss by regulating bone formation and bone resorption.
Yang YT; Meng JH; Hu B; Ma CY; Zhao CC; Teng WS; Hong JQ; Li SH; Jiang GY; Wang C; Zhou CH; Yan SG
Life Sci; 2018 Sep; 209():409-419. PubMed ID: 30096387
[TBL] [Abstract][Full Text] [Related]
16. Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss.
Stubelius A; Andersson A; Holmdahl R; Ohlsson C; Islander U; Carlsten H
BMC Musculoskelet Disord; 2016 Nov; 17(1):464. PubMed ID: 27829407
[TBL] [Abstract][Full Text] [Related]
17. Anti-Osteoporotic Effect of Morroniside on Osteoblast and Osteoclast Differentiation In Vitro and Ovariectomized Mice In Vivo.
Lee CG; Kim J; Yun SH; Hwang S; Jeon H; Park E; Jeong SY
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638983
[TBL] [Abstract][Full Text] [Related]
18. Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models.
Chung HJ; Kyung Kim W; Joo Park H; Cho L; Kim MR; Kim MJ; Shin JS; Ho Lee J; Ha IH; Kook Lee S
J Ethnopharmacol; 2016 Feb; 179():66-75. PubMed ID: 26712566
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitor quisinostat prevents estrogen deficiency-induced bone loss by suppressing bone resorption and promoting bone formation in mice.
Sun S; Xiu C; Chai L; Chen X; Zhang L; Liu Q; Chen J; Zhou H
Eur J Pharmacol; 2022 Jul; 927():175073. PubMed ID: 35636521
[TBL] [Abstract][Full Text] [Related]
20. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
